Published in Stroke on February 13, 2003
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest (2005) 3.22
Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ (2006) 1.79
Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nat Med (2009) 1.45
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain (2008) 1.40
Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience (2006) 1.35
Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci (2008) 1.28
G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J Exp Med (2007) 1.24
Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp Neurol (2007) 1.21
Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology (2007) 1.17
Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab (2012) 1.03
Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics (2009) 1.03
A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A (2005) 1.03
Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke. Stem Cells Transl Med (2014) 1.02
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Exp Transl Stroke Med (2009) 1.01
The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol (2012) 1.00
The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats. Brain Res (2007) 0.99
An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol (2006) 0.98
Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats. Intensive Care Med (2010) 0.98
Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics (2011) 0.98
New hope for stroke patients: mobilization of endogenous stem cells. CMAJ (2006) 0.97
Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res (2007) 0.95
Growth factors in ischemic stroke. J Cell Mol Med (2009) 0.94
Comparison of transplantation of bone marrow stromal cells (BMSC) and stem cell mobilization by granulocyte colony stimulating factor after traumatic brain injury in rat. Iran Biomed J (2010) 0.94
Growth factors and stroke. NeuroRx (2006) 0.93
Granulocyte stimulating factor attenuates hypoxic-ischemic brain injury by inhibiting apoptosis in neonatal rats. Yonsei Med J (2008) 0.92
Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Negl Trop Dis (2012) 0.92
Trophic factors and cell therapy to stimulate brain repair after ischaemic stroke. J Cell Mol Med (2012) 0.90
Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor. J Neurosurg Sci (2014) 0.90
Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip. PLoS One (2016) 0.89
The potential benefit of stem cell therapy after stroke: an update. Vasc Health Risk Manag (2012) 0.89
The receptor for granulocyte-colony stimulating factor (G-CSF) is expressed in radial glia during development of the nervous system. BMC Dev Biol (2008) 0.88
Neuroprotective therapy using granulocyte colony-stimulating factor for patients with worsening symptoms of compression myelopathy, Part 1: a phase I and IIa clinical trial. Eur Spine J (2011) 0.86
Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke. Transl Stroke Res (2015) 0.86
Neuronal hypoxia in vitro: investigation of therapeutic principles of HUCB-MNC and CD133+ stem cells. BMC Neurosci (2008) 0.85
Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment. Transl Stroke Res (2012) 0.85
Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy. BMC Neurosci (2009) 0.85
Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats. PLoS One (2012) 0.85
Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats. Front Cell Neurosci (2014) 0.84
Stem cell therapy in stroke: a review literature. Int J Prev Med (2013) 0.83
Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis. J Cereb Blood Flow Metab (2014) 0.83
Granulocyte colony-stimulating factor treatment provides neuroprotection in surgically induced brain injured mice. Acta Neurochir Suppl (2011) 0.83
G-CSF attenuates neuroinflammation and stabilizes the blood-brain barrier via the PI3K/Akt/GSK-3β signaling pathway following neonatal hypoxia-ischemia in rats. Exp Neurol (2015) 0.83
Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial. Eur Spine J (2012) 0.83
Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trial. PLoS One (2011) 0.83
Epo and other hematopoietic factors. Semin Fetal Neonatal Med (2007) 0.83
Role of the pituitary–adrenal axis in granulocyte-colony stimulating factor-induced neuroprotection against hypoxia–ischemia in neonatal rats. Neurobiol Dis (2012) 0.82
Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial Cells. Evid Based Complement Alternat Med (2008) 0.82
Combination of stem cell mobilized by granulocyte-colony stimulating factor and human umbilical cord matrix stem cell: therapy of traumatic brain injury in rats. Iran J Basic Med Sci (2011) 0.82
Mobilization of Stem Cells Using G-CSF for Acute Ischemic Stroke: A Randomized Controlled, Pilot Study. Stroke Res Treat (2011) 0.82
The role of stem cell factor and granulocyte-colony stimulating factor in treatment of stroke. Recent Pat CNS Drug Discov (2013) 0.82
G-CSF administration is neuroprotective following transient cerebral ischemia even in the absence of a functional NOS-2 gene. J Cereb Blood Flow Metab (2010) 0.81
LIM domain only 4 protein promotes granulocyte colony-stimulating factor-induced signaling in neurons. Cell Mol Life Sci (2009) 0.81
Effect of granulocyte-colony stimulating factor on expression of selected proteins involved in regulation of apoptosis in the brain of newborn piglets after cardiopulmonary bypass and deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg (2012) 0.81
Granulocyte colony-stimulating factor promotes behavioral recovery in a mouse model of traumatic brain injury. J Neurosci Res (2016) 0.81
Synergetic effects of granulocyte-colony stimulating factor and cognitive training on spatial learning and survival of newborn hippocampal neurons. PLoS One (2009) 0.80
Schizandrin A Inhibits Microglia-Mediated Neuroninflammation through Inhibiting TRAF6-NF-κB and Jak2-Stat3 Signaling Pathways. PLoS One (2016) 0.79
Neutrophil contribution to spinal cord injury and repair. J Neuroinflammation (2014) 0.79
Cinepazide maleate protects PC12 cells against oxygen-glucose deprivation-induced injury. Neurol Sci (2013) 0.79
G-CSF ameliorates neuronal apoptosis through GSK-3β inhibition in neonatal hypoxia-ischemia in rats. Exp Neurol (2014) 0.79
The potential of hematopoietic growth factors for treatment of Alzheimer's disease: a mini-review. BMC Neurosci (2008) 0.78
Protection of taurine and granulocyte colony-stimulating factor against excitotoxicity induced by glutamate in primary cortical neurons. J Biomed Sci (2010) 0.78
JAK2/STAT3 pathway mediating inflammatory responses in heatstroke-induced rats. Int J Clin Exp Pathol (2015) 0.77
Intravenous administration of granulocyte colony-stimulating factor for treating neuropathic pain associated with compression myelopathy: a phase I and IIa clinical trial. Eur Spine J (2012) 0.77
Granulocyte-colony stimulating factor improves MDX mouse response to peripheral nerve injury. PLoS One (2012) 0.77
Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysis. Sci Rep (2016) 0.76
Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice. Int J Mol Sci (2016) 0.76
Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model. Neurobiol Dis (2014) 0.76
A screen for peptide agonists of the G-CSF receptor. BMC Res Notes (2011) 0.75
pH responsive granulocyte colony-stimulating factor variants with implications for treating Alzheimer's disease and other central nervous system disorders. Protein Eng Des Sel (2015) 0.75
Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro. Stem Cell Res Ther (2017) 0.75
Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease. J Anat (2014) 0.75
Efficacy of granulocyte-colony stimulating factor treatment in a rat model of anterior ischemic optic neuropathy. Neural Regen Res (2014) 0.75
Electroacupuncture induces acute changes in cerebral cortical miRNA profile, improves cerebral blood flow and alleviates neurological deficits in a rat model of stroke. Neural Regen Res (2016) 0.75
Granulocyte colony stimulating factor reduces brain injury in a cardiopulmonary bypass-circulatory arrest model of ischemia in a newborn piglet. Neurochem Res (2014) 0.75
G-CSF and hypoxic conditioning improve the proliferation, neural differentiation and migration of canine bone marrow mesenchymal stem cells. Exp Ther Med (2016) 0.75
G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke. Exp Transl Stroke Med (2010) 0.75
Effect of Intravenous Infusion of G-CSF-Mobilized Peripheral Blood Mononuclear Cells on Upper Extremity Function in Cerebral Palsy Children. Ann Rehabil Med (2017) 0.75
Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined With Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis. Cell Med (2011) 0.75
Role of Endogenous Bone Marrow Stem Cells Mobilization in Repair of Damaged Inner Ear in Rats. Int J Stem Cells (2015) 0.75
Sevoflurane postconditioning protects the myocardium against ischemia/reperfusion injury via activation of the JAK2-STAT3 pathway. PeerJ (2017) 0.75
Granulocyte-Colony Stimulating Factor Increases Cerebral Blood Flow via a NO Surge Mediated by Akt/eNOS Pathway to Reduce Ischemic Injury. ScientificWorldJournal (2015) 0.75
Combination of endogenous neural stem cell mobilization and lithium chloride treatment for hydrocephalus following intraventricular hemorrhage. Exp Ther Med (2016) 0.75
Effects of an Inhibitor of Monocyte Recruitment on Recovery from Traumatic Brain Injury in Mice Treated with Granulocyte Colony-Stimulating Factor. Int J Mol Sci (2017) 0.75
Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke. J Neuroinflammation (2017) 0.75
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83
'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol (1996) 3.70
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol (2005) 3.17
NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med (1999) 2.96
Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene (1996) 2.73
[Definition, classification and diagnosis of fibromyalgia syndrome]. Schmerz (2008) 2.38
Waiting for platelet counts causes unsubstantiated delay of thrombolysis therapy. Eur Neurol (2013) 2.13
Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med (2013) 1.96
NF-kappaB signaling in cerebral ischemia. Neuroscience (2008) 1.88
Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology (2010) 1.80
Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res (1997) 1.73
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke (2004) 1.66
EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol (2010) 1.63
Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology (2000) 1.62
[Therapy of Frey syndrome with botulinum toxin A. Experiences with a new method of treatment]. HNO (1995) 1.62
Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity (1999) 1.59
The role of E2F in the mammalian cell cycle. Biochim Biophys Acta (1993) 1.59
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke (2000) 1.55
CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (2012) 1.55
Effect of corticosteroids on short-term and long-term memory. Neurology (2005) 1.54
Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med (2000) 1.52
Sonographic monitoring of ventricle enlargement in posthemorrhagic hydrocephalus. Neurology (2011) 1.49
Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol (2008) 1.45
Does acute occlusion of the carotid T invariably have a poor outcome? Neurology (2004) 1.44
Von Willebrand disease caused by compound heterozygosity for p.r854q and p.r760c: diagnostic and therapeutic implications. Haemophilia (2010) 1.39
[Cerebrotendinous xanthomatosis, a treatable metabolic disorder]. Nervenarzt (2002) 1.39
[Infection: impaired consciousness as the initial symptom. Clinical and pathophysiologic aspects of septic encephalopathy]. Nervenarzt (1997) 1.39
Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Lab Invest (1996) 1.38
Cerebral autoregulation under moderate hypothermia in patients with acute stroke. Stroke (2002) 1.38
Acid-base management--is it relevant for the study design of hypothermic neuroprotection? Eur J Anaesthesiol (2002) 1.38
Decompressive surgery in space-occupying hemispheric infarction: results of an open, prospective trial. Crit Care Med (1995) 1.33
Flat detector CT in the evaluation of brain parenchyma, intracranial vasculature, and cerebral blood volume: a pilot study in patients with acute symptoms of cerebral ischemia. AJNR Am J Neuroradiol (2010) 1.31
Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann Neurol (2001) 1.29
Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J Cereb Blood Flow Metab (1997) 1.27
Safety and outcome after thrombolysis in stroke patients with mild symptoms. Cerebrovasc Dis (2008) 1.23
Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke (2000) 1.23
Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol (2000) 1.19
Common polymorphisms in the coding part of the IL4-receptor gene. Biochem Biophys Res Commun (1997) 1.16
Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke (1998) 1.14
Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis (2001) 1.14
The htpG gene of Bacillus subtilis belongs to class III heat shock genes and is under negative control. J Bacteriol (1997) 1.13
Delayed neuroprotective effect of insulin-like growth factor-i after experimental transient focal cerebral ischemia monitored with mri. Stroke (2001) 1.12
Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology (Oxford) (2005) 1.11
Selective stimulation of either tumor necrosis factor receptor differentially induces pain behavior in vivo and ectopic activity in sensory neurons in vitro. Neuroscience (2008) 1.11
Induction of interleukin-6 by depolarization of neurons. J Neurosci (2000) 1.10
The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J Neuroimmunol (2004) 1.08
[Fumaric acid or dimethyl fumarate?]. Nervenarzt (2015) 1.08
Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci Lett (2001) 1.06
Endovascular cooling for moderate hypothermia in patients with acute stroke: first results of a novel approach. Stroke (2001) 1.06
Fracture of the lateral process of the talus in snowboarders. J Bone Joint Surg Br (2007) 1.06
Off-label thrombolysis for acute ischemic stroke: rate, clinical outcome and safety are influenced by the definition of 'minor stroke'. Cerebrovasc Dis (2011) 1.06
Cardiovascular autonomic function in poststroke patients. Neurology (2007) 1.04
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol (2006) 1.04
Small-fiber neuropathy in patients with ALS. Neurology (2011) 1.04
[OSCE in the neurology clerkship. Experiences at the neurological department of the university hospital Erlangen]. Fortschr Neurol Psychiatr (2008) 1.03
Acute disseminated encephalomyelitis after parenteral therapy with herbal extracts: a report of two cases. J Neurol Neurosurg Psychiatry (2000) 1.03
Hypothermia induced by atypical neuroleptics. Clin Neuropharmacol (1999) 1.02
Desmin and actin associated with cytoplasmic bodies in skeletal muscle fibers: immunocytochemical and fine structural studies, with a note on unusual 18- to 20-nm filaments. Acta Neuropathol (1990) 1.02
Characterization of the 5' end of the growth-regulated Syrian hamster CAD gene. Cell Growth Differ (1990) 1.02
Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res (2000) 1.02
Poliomyelitic-like illness in central European encephalitis. Neurology (2000) 1.02
Effects of peer-assisted training during the neurology clerkship: a randomized controlled study. Eur J Neurol (2008) 1.01
Contralateral cytokine gene induction after peripheral nerve lesions: dependence on the mode of injury and NMDA receptor signaling. Brain Res Mol Brain Res (2005) 1.01
Small fibre neuropathy in sarcoidosis. Lancet (2002) 1.01
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry (2010) 1.00
Degradation of 1,4-dichlorobenzene by Xanthobacter flavus 14p1. Appl Environ Microbiol (1995) 0.99
Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia. Cell Death Differ (2011) 0.98
Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res (1998) 0.98
[Quality improvement of multiple choice examinations: in psychiatry, psychosomatic medicine, psychotherapy, and neurology]. Nervenarzt (2009) 0.98
Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. J Neurol (2013) 0.97
Meningeal involvement in Wegener's granulomatosis confirmed and monitored by positive circulating antineutrophil cytoplasm in cerebrospinal fluid. Neurology (1997) 0.97
New techniques in indirect reduction of long bone fractures. Clin Orthop Relat Res (1998) 0.97
Restricted diffusion within ring enhancement is not pathognomonic for brain abscess. AJNR Am J Neuroradiol (2001) 0.96
A functional serotonin transporter gene polymorphism is associated with migraine with aura. Neurology (2005) 0.96
Granzyme-b is involved in mediating post-ischemic neuronal death during focal cerebral ischemia in rat model. Neuroscience (2009) 0.96
Foot movement and tendon excursion: an in vitro study. Foot Ankle Int (1994) 0.95
Familial mental retardation syndrome ATR-16 due to an inherited cryptic subtelomeric translocation, t(3;16)(q29;p13.3). Am J Hum Genet (2000) 0.95
Effect and feasibility of controlled rewarming after moderate hypothermia in stroke patients with malignant infarction of the middle cerebral artery. Stroke (2001) 0.95
Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol (1999) 0.95
Neuroendocrine changes in patients with acute space occupying ischaemic stroke. J Neurol Neurosurg Psychiatry (2003) 0.95
Brain-derived neurotrophic factor improves long-term potentiation and cognitive functions after transient forebrain ischemia in the rat. Exp Neurol (1999) 0.95
Combination of decompressive craniectomy and mild hypothermia ameliorates infarction volume after permanent focal ischemia in rats. Stroke (2001) 0.94
Predictive value of serum interleukin-6 and -8 levels in preterm labor or rupture of the membranes. Acta Obstet Gynecol Scand (2000) 0.94